Literature DB >> 6332942

The predictive factor--a method to simplify Bayes' formula and its application to diagnostic procedures.

J Köbberling, K Richter, H Tillil.   

Abstract

According to Bayes' rule the predictive value (PV) of a diagnostic test (= probability of disease if the test is positive) depends on the prevalence of the disease (= a priori probability), the sensitivity (c1) and the specificity (c2) of the test. A new variable has been introduced, the predictive factor (c), which is calculated as follows: c = c1/(c1 +1 -c2). Since the PV only depends on this factor and on the prevalence, the calculation is much easier and a general graphical solution is possible. This simplification renders several additional advantages and facilitates the understanding of the dependence of PV on prevalence.

Mesh:

Substances:

Year:  1984        PMID: 6332942     DOI: 10.1007/bf01728177

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  5 in total

1.  Letter: Nomogram for Bayes theorem.

Authors:  T J Fagan
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

2.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

3.  A probability graph describing the predictive value of a highly sensitive diagnostic test.

Authors:  M A Katz
Journal:  N Engl J Med       Date:  1974-11-21       Impact factor: 91.245

4.  [Predictive value of diagnostic procedures].

Authors:  J Köbberling
Journal:  Dtsch Med Wochenschr       Date:  1982-04-16       Impact factor: 0.628

Review 5.  The human major histocompatibility complex and endocrine disease.

Authors:  N R Farid; J C Bear
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

  5 in total
  3 in total

Review 1.  [Principles for evaluating simple, diagnostic tests].

Authors:  K Richter; U Abel; R Klar; J Köbberling; H J Trampisch; J Windeler
Journal:  Klin Wochenschr       Date:  1988-08-01

2.  [Empirical study of the assessment of diagnostic procedures as exemplified by the Hemoccult test].

Authors:  J Windeler; J Köbberling
Journal:  Klin Wochenschr       Date:  1986-10-31

3.  HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors.

Authors:  B O Boehm; P Kühnl; C Löliger; U Ketzler-Sasse; G Holzberger; S Seidl; R Bäuerle; E Schifferdecker; K H Usadel
Journal:  Clin Investig       Date:  1993-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.